|
The most common question primary care providers ask about specific
IgE testing is “How will it change the way I treat my patients?” Results
from specific IgE testing can make a significant difference in the
way you manage patients who present with allergy-like symptoms. The
best treatment decisions are based on quantifiable clinical evidence.
Specific IgE measurement can rule out or confirm allergy, and the
results will help you design a management plan (using avoidance,
appropriate medication, or referral when necessary) that will get your patients
on the path to feeling better.
Today’s ImmunoCAP® Specific IgE blood test
is making allergy testing more reliable than ever. ImmunoCAP has
been cleared by the FDA as a truly quantitative measure of IgE.
ImmunoCAP results can help rule atopy in or out, and when positive,
identify—and quantify—specific
allergen sensitivities.
Treatment Options
Appropriate management of patients
with allergy-like symptoms begins with an accurate assessment of
specific IgE antibodies through testing. Management decisions will
differ for the allergic patient and the non-allergic patient, so
specific IgE testing to rule in or rule out an allergic etiology
can help guide treatment.
|
